NEU neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-122

  1. 2,524 Posts.
    lightbulb Created with Sketch. 690
    Same. I recommend ignoring low value posters who have nothing useful to contribute. There's so many great posters on this sub-forum who are levelheaded. There's so much to look forward to in the future of this company. We have an amazing foundation set with Daybue, and have 3 more phase 2 trial read outs to look forward to.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.